作者：
Lucia,Sobrin [1]
;
Maxwell,Pistilli [2]
;
Kurt,Dreger [3]
;
Srishti,Kothari [4]
;
Naira,Khachatryan [5]
;
Pichaporn,Artornsombudh [6]
;
Siddharth S,Pujari [7]
;
C Stephen,Foster [8]
;
Douglas A,Jabs [9]
;
Robert B,Nussenblatt [10]
;
James T,Rosenbaum [11]
;
Grace A,Levy-Clarke [12]
;
H Nida,Sen [10]
;
Eric B,Suhler [13]
;
Jennifer E,Thorne [14]
;
Nirali P,Bhatt [2]
;
John H,Kempen [15]
;
Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group
作者单位：
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. Electronic address: Lucia_Sobrin@meei.harvard.edu.
[1]
Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.
[2]
Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Ophthalmology, The Johns Hopkins School of Medicine, Baltimore, Maryland.
[3]
Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania; Department of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts.
[4]
Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts.
[5]
Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts; Department of Ophthalmology, Somdech Phra Pinkloa Hospital, Royal Thai Navy, Bangkok, Thailand; Department of Ophthalmology, Chulalongkorn University, Bangkok, Thailand.
[6]
Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts; Siddharth Netralaya, Belgaum, Karnataka, India.
[7]
Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts.
[8]
Departments of Ophthalmology and Medicine, The Icahn School of Medicine at Mount Sinai, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
[9]
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
[10]
Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon; Department of Medicine, Oregon Health and Science University, Portland, Oregon; Legacy Devers Eye Institute, Portland, Oregon.
[11]
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland; The Tampa Bay Uveitis Center, St. Petersburg, Florida.
[12]
Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon; Department of Ophthalmology, Portland Veteran's Affairs Medical Center, Portland, Oregon.
[13]
Department of Ophthalmology, The Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
[14]
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; MCM Eye Unit, MyungSung Christian Medical Center and MyungSung Medical School, Addis Ababa, Ethiopia.
[15]
DOI
10.1016/j.ophtha.2019.11.020
PMID
31932091
发布时间
2021-06-02
换一批
换一批
